Background-Patients who undergo tricuspid annuloplasty during left-side heart valve surgery have a poor postoperative clinical outcome. However, preoperative right ventricular (RV) echocardiography parameters that predict adverse events in these patients are poorly understood. Methods and Results-We studied 74 patients (age, 58±10 years; men, 27%) with significant tricuspid regurgitation who consequently underwent tricuspid annuloplasty during left-side heart valve surgery. A total of 26 adverse events (22 heart failures and 4 cardiovascular deaths) occurred during a median follow-up of 26 months. RV midcavity diameter (hazard ratio=2.44; 95% confidence interval=1.48-4.02; P<0.01), RV longitudinal dimension (hazard ratio=1.64; 95% confidence interval=1.10-2.45; P=0.02), and tricuspid valve tethering area (hazard ratio=3.25; 95% confidence interval=1.71-6.19; P<0.01) were independently associated with adverse events after adjustment for age and New York Heart Association class III/IV. Receiver-operator characteristic curve analysis demonstrated that RV midcavity diameter (area under the curve=0.74; P<0.01) and tricuspid valve tethering area (area under the curve=0.70; P=0.04) were most associated with adverse events at the 1-year follow-up. The presence of either a large RV midcavity diameter or tricuspid valve tethering area was predictive of adverse outcome at 1 year after tricuspid annuloplasty. Conclusions-The present study demonstrates that RV geometry dimensions, namely RV midcavity diameter and tricuspid valve tethering area, are important preoperative measures associated with adverse events in patients undergoing tricuspid annuloplasty. P=0.89, respectively). NYHA classification was given as class I/II and class III/IV. Adverse outcome was defined as the occurrence of heart failure requiring admission or cardiovascular mortality. All outcomes were retrieved from the interhospital system or through telephone interviews. The study was part of the Chinese Valvular Heart Disease Study (CVATS) to evaluate Chinese patients with valvular heart disease in an attempt to evaluate the pattern of disease, pathophysiology, and clinical outcome in these patients. The study was approved by ethics committee of the West Cluster Hospital Authority of Hong Kong. Subjects gave informed consent.
S
ignificant tricuspid regurgitation (TR) secondary to leftside heart valve disease is associated with mortality and decreased functional outcome. 1, 2 Thus, in such patients, tricuspid annuloplasty (TA) during left-side heart valve surgery is advocated to reduce TR. 3, 4 Although TA can reduce and prevent the progression of TR and improve right ventricular (RV) reverse remodeling, the 10-year survival in these patients is limited to 50% to 66%. [5] [6] [7] [8] Surgical indications and types of surgery have been poorly described in patients undergoing TA, 3, 4 and few clinical reports have evaluated patients' prognosis to determine the predictors of adverse outcome. Parameters such as laboratory testing, 9, 10 New York Heart Association (NYHA) class, 10 and RV function 11 have been shown to be prognostic factors for these patients. However, the prognostic implications of RV echocardiography parameters have not been studied.
Clinical Perspective on p 92
Most TR is caused by altered RV geometry and tricuspid valve (TV) annular dilation secondary to left-side heart disease. 12, 13 The TV tethering area is also associated with postoperative TR, which may subsequently affect clinical outcome. 14 The importance of these parameters as determinants of outcome in patients undergoing TA is unknown. The aim of the present study thus was to evaluate the prognostic value of preoperative RV geometry and TV dimension in patients undergoing TA.
Methods Study Population and Design
A total of 166 consecutive patients who underwent elective TA at the Grantham Hospital and Queen Mary Hospital between January 2007 and January 2011 were evaluated. Patients were excluded if their offline echocardiography examination was not available for further analysis (n=52) or if the image was not focused on the RV for detailed geometry (n=34) and TV annular assessment (n=6). The remaining 74 patients included in the study were followed up in the outpatient clinic, and no patients were lost to follow-up. Baseline demographics between patients who were included (n=74) and excluded (n=92) for the present study were similar ( . NYHA classification was given as class I/II and class III/IV. Adverse outcome was defined as the occurrence of heart failure requiring admission or cardiovascular mortality. All outcomes were retrieved from the interhospital system or through telephone interviews. The study was part of the Chinese Valvular Heart Disease Study (CVATS) to evaluate Chinese patients with valvular heart disease in an attempt to evaluate the pattern of disease, pathophysiology, and clinical outcome in these patients. The study was approved by ethics committee of the West Cluster Hospital Authority of Hong Kong. Subjects gave informed consent.
Echocardiography Parameters
Echocardiography evaluation was performed preoperatively with a commercially available system (iE33, Philips Medical Systems, Andover, MA) with the patient in the left lateral decubitus position. LV volume and LV ejection fraction were measured according to the current recommendations. 15 Right atrial area was measured by planimetry from the apical 4-chamber view with the largest right atrial size at end systole. 16 Pulmonary arterial systolic pressure was estimated by RV systolic pressure, which was calculated from the TR peak gradient with the modified Bernoulli equation 4V 2 with the addition of right atrial pressure. 17 Right atrial pressure was estimated according to the inferior vena cava diameter and its collapsibility as recommended. 17 Apical 4-chamber views focusing particularly on the RV (RV-focused view) were performed to facilitate accurate RV dimension assessment. 17 To optimize imaging of the RV lateral wall, the apical 4-chamber was adjusted from its focus on the LV. Right ventricular end-systolic area (RVESA) and end-diastolic area (RVEDA) were measured by manually tracing the RV endocardial border on the apical 4-chamber view; care was taken to obtain a true nonforeshortened view oriented to produce the maximum RV dimension. The RV fractional area change was calculated from the following equation: (RVEDA−RVESA)/RVEDA×100%. 15 From the same view, the basal and midcavity RV diameters and the RV longitudinal dimension were obtained (Figure 1) . 15 The basal diameter was defined as the maximal short-axis dimension in the basal one third of the RV seen on the 4-chamber view. The midcavity diameter was measured in the middle third of the RV at the level of LV papillary muscles. The longitudinal dimension is the distance from the plane of the tricuspid annulus to the RV apex. Systolic RV area was divided by RV longitudinal dimension (measured from the tip of the true RV apex to the midpoint of TV annular plane) to calculate the RV spherical index. Minimal TV annular dimension was measured at the end diastole from the insertion of the septal leaflet to the insertion of the anterior leaflet. Finally, the tethering area was calculated as the area between the atrial surface of the leaflets and the annulus plane at end systole ( Figure 1 ). 14 Residual significant TR was defined as moderate or severe TR on the basis of the results of the transthoracic echocardiography examination before discharge of patients after TA surgery.
Statistical Analysis
Continuous variables are expressed as mean±SD and compared by use of the Student t test. The Wilcoxon signed-rank test was used to compare NYHA class. Categorical variables are reported as frequencies and compared by use of the χ 2 or Fisher exact test if at least 1 cell had an expected cell count <5. Intraobserver agreement and interobserver agreement for RV geometry dimension (RV basal and midcavity diameter, RV longitudinal dimension, and TV annular diameter) and tethering area were evaluated by Bland-Altman analysis, and intraclass correlation coefficients were calculated as indicators of reproducibility from 10 randomly selected patients. Cox regression model adjusted for age and NYHA class III/IV was performed to determine independent variables of RV parameters associated with adverse events. The Harrell C index was calculated to estimate the discrimination power of individual RV parameters and known prognostic factors such as age, NYHA, preoperative LV ejection fraction, and pulmonary arterial systolic pressure. The higher the Harrell C statistic is, the better the model discriminates the adverse outcome. The Harrell C statistic was performed with R software (http://www. r-project.org/). To take into account the time-dependent characteristics of receiver-operating characteristic curves, the prognostic model was assessed with the receiver-operating characteristic curves at the 1-year follow-up. The optimal cutoff value was defined as the maximized value for the sum of sensitivity and specificity. All statistical analyses were performed with the SPSS statistical package for Windows (version 17.0, SPSS, Chicago, IL). A value of P<0.05 was considered statistically significant.
Results

Baseline Characteristics
The mean age of the study population was 58±10 years; 20 (27%) were male. The majority of patients had underlying atrial fibrillation, and 73% had chronic rheumatic heart disease as the reason for the valve pathology. The mean pulmonary arterial systolic pressure before TA was 51.7 mm Hg (range, 26 to 85 mm Hg). All patients had previously undergone mitral valve surgery, and 20 had concomitant aortic valve replacement at the time of TA. More than 90% of patients had undergone ring annuloplasty; the remaining received a De Vega annuloplasty. Only 2 patients had significant coronary artery disease that required simultaneous coronary artery bypass graft.
Adverse Outcome
Median follow-up after TA was 26 months (range, 1-66 months). A total of 26 adverse events occurred during the follow-up period: 22 patients developed heart failure (21 patients had congestive heart failure, 1 patient had predominant right heart failure), and 4 died (2 deaths related to heart failure, 2 sudden deaths). Patient demographics are shown in Table 1 , and none of them was associated with adverse events. The echocardiography parameters of these patients are shown in Table 2 . A larger RV midcavity diameter, RV longitudinal dimension, and TV tethering area were associated with adverse events. The LV dimension, LV ejection fraction, RV dimension, and RV fractional area change, however, did not show such an association.
Multivariable Cox regression analysis adjusted for age and NYHA class was performed for each right heart parameter to look for independent variables associated with an adverse event (Table 3) . Results revealed that RV midcavity diameter, RV longitudinal dimension, and TV tethering area were all independent variables associated with adverse event in patients undergoing TA. Conversely, RV basal diameter, RV 
RV Midcavity Diameter and TV Tethering Area Are Associated With Adverse Event at the 1-Year Follow-Up
The receiver-operating characteristic curve was generated to determine the accuracy of the individual RV geometry dimension and TV tethering area in association with adverse events at the 1-year follow-up. All patients had at least 1 year of follow-up. As shown in Figure 2 , RV midcavity diameter and TV tethering area were significantly associated with adverse events. Both right atrial midcavity diameter and TV tethering area had the largest area under the curve and thus were used to calculate optimal cutoff values for association with adverse events at the 1-year follow-up. A cutoff value of >3.2 cm for RV midcavity diameter (n=32) provided a sensitivity of 73% and specificity of 62%, whereas a cutoff value of 0.85 cm 2 for TV tethering area (n=38) showed a sensitivity of 82% and specificity of 54%. A combination of >3.2-cm RV midcavity diameter and >0.85-cm 2 TV tethering area had a sensitivity of 66%, a specificity of 71%, a positive predictive value of 24%, and a negative predictive value of 94%. Importantly, the presence of either >3.2-cm RV midcavity diameter or >0.85-cm 2 TV tethering area had a sensitivity of 100%, a specificity of 32%, a positive predictive value of 20%, and a negative predictive value of 100%.
Reproducibility
Interobserver and intraobserver variabilities for RV geometry measurements and tethering area were evaluated by 2 independent observers. The results are shown in Table 4 .
Discussion
The present study demonstrates that patients who underwent TA and who developed a postoperative adverse event had a larger RV mid-cavity diameter, RV longitudinal dimension, and TV tethering area, even after multivariable adjustment for age and NYHA class. The Harrell C index revealed that RV midcavity diameter and TV tethering area provided a better discrimination power of adverse events compared with other RV parameters and known prognostic factors. The receiveroperating characteristic curve demonstrated that RV midcavity diameter and TV tethering area were most associated with adverse events at the 1-year follow-up. Importantly, the presence of either >3.2-cm RV midcavity diameter or >0.85-cm 2 TV tethering area may predict future adverse events in patients undergoing TA after 1 year of follow-up.
For effective repair of TV by TA, maintenance of a harmonious coupling between tricuspid leaflets, annulus, chordae, and papillary muscle is essential. 13 Failure of any 1 of these structures during TA will cause residual TR and increase the subsequent risk for adverse events. Similar to mitral regurgitation, 18 an altered RV geometry displaces TV papillary muscle and position for chordae insertion, leading to inadequate leaflet coaptation, which closely correlates with the severity of TR. 19, 20 The position of the papillary muscle is usually at the RV midcavity; thus, RV midcavity diameter measured in the present study may reflect the position of the anterior and septal papillary muscles of the RV. The larger diameter at the RV midcavity would thus suggest a greater displacement of the papillary muscle of the TV. Because of this, TA (with or without a ring) in patients with an enlarged RV midcavity may not be able to proximate the displaced papillary muscle for effective TV closure, leading to a poor postoperative outcome. Indeed, an ex vivo study has recently demonstrated that the addition of RV papillary muscle approximation better repaired TR than TA alone by improving both RV geometry and valve tethering. 21 The possibility for this surgical technique to improve clinical outcomes in patients with TR and dilated RV midcavity nonetheless requires study in humans.
Leaflet tethering of TV is another important determinant of TR and is closely related to papillary position and RV geometry. 19, 22, 23 Tethering area, measured by both 2-dimensional 14 and 3-dimensional echocardiography, 24 has been shown to be predictive of residual TR after TV surgery. The present study extended these findings by confirming that a large TV tethering area was associated with adverse events after TA. Currently, annuloplasty only treated annular dilatation and could not reduce leaflet tethering. Because effective reduction of tethering is the key to successful TV surgery, additional surgical techniques besides TA alone should be considered. In selected cases, TV leaflet augmentation may be a surgical option to reduce leaflet tethering. 25, 26 In advanced forms of TV tethering, TA may be inadequate and valve replacement should be considered. The TV tethering area should therefore be measured preoperatively so that the most suitable type of TV surgery can be selected and the clinical outcome optimized.
Clinical Implications
The timing of surgical intervention for TR secondary to leftside heart valve disease is determined mainly by the time of left-side heart valvular surgery as recommended by the current guidelines. 3, 4 However, the relatively poor 10-year survival for patients after TA provides further supports that the current recommendations, based on left-side heart valve disease status, cannot fully determine the optimal timing for TR surgery. Measures that provide additional information and improve risk stratification for patients undergoing TA are thus necessary. In the present study, patients with an enlarged RV midcavity and tethering area were at high risk of an adverse event. This finding demonstrates that early TA, before alteration of the RV geometry and excessive TV tethering, can improve clinical outcome. It is consequently clinically relevant to consider both RV geometry and TV tethering area when determining optimal surgical timing, independently of the status of left-side heart valve disease. Furthermore, these parameters should also be considered for the mode of TV surgery to be performed.
Limitations
In the present study, the measurement of papillary muscle displacement was not evaluated. Because some papillary muscle has been described as "fused papillary muscle" and is directly attached to the wall, identifying the accurate papillary muscle position of TV with conventional echocardiography is technically difficult. 27 Furthermore, only 2-dimensional echocardiographic parameters were used to evaluate RV geometry and TV tethering. Novel 3-dimensional echocardiography geometric assessment could be used to confirm the present findings. The present study included only patients undergoing TA together with left-side heart valve surgery; results should be verified in patients with isolated TR. Current recommendations suggest that TV surgery be considered for severe isolated TR only when symptoms of heart failure are present. 3, 4 However, symptom-based surgery carries a dismal outcome, 9, 28 and surgery based on RV geometry and TV dimension, before the development of symptoms, can improve surgical outcome in this group of patients. Because of the small sample size, determining the potential independent association between individual RV geometry, particularly RV midcavity and basal diameters and TV tethering area, with adverse events was not feasible. Furthermore, a larger sample size is required to validate the cutoff value suggested in the present study in association with adverse events at the 1-year follow-up. Finally, patients evaluated in the present study were Asian; confirmatory studies in other ethnic groups are required.
Conclusions
This study demonstrates that enlarged RV midcavity diameter and TV tethering area were independently associated with adverse events in patients undergoing TA. Importantly, the presence of either >3.-2cm RV midcavity diameter or >0.85-cm 2 TV tethering area provided excellent sensitivity and negative predictive value for future adverse events at the 1-year follow-up. Addressing these parameters with preoperative echocardiography may improve risk stratification in patients undergoing TA. 
